HE-S2 NEW

$1520.00 25mg

$1980.00 50mg

$2500.00 100mg

TargetMol Chemicals Inc.

1YR

United States

Chemical Properties

Company Profile Introduction

Name	HE-S2
Description	HE-S2, an antibody-drug conjugate, elicits a potent antitumor immune response by inhibiting the PD-1/PD-L1 interaction and stimulating the Toll-like receptor 7/8 (TLR7/8) signaling pathway, resulting in significant antitumor activity [1].
In vitro	HE-S2 (10 ng; 30 min) effectively targets and binds to PD-L1 in MC38 cells [1].
Storage	Shipping with blue ice.
Inhibitors Related	LSD1-IN-24 \| PD-1/PD-L1-IN-9 \| Sulfamethoxypyridazine \| PD-1-IN-22 \| BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride \| IMMH 010 maleate \| Mc-VC-PAB-SN38 \| LSD1-IN-27 \| BMS-1 \| PD-L1-IN-3